---

$24.55

N/A ( 0% ) 11.5K

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-04-10	Sale	-800.00	Bernstein Bruce
2024-04-10	Sale	-800.00	SCHECHTER JONATHAN
2024-04-10	Sale	-800.00	Silverman Joshua
2024-04-10	Sale	-800.00	Singer William S.